XBKK
CHG
Market cap484mUSD
Nov 12, Last price
1.48THB
Name
Chularat Hospital PCL
Chart & performance
P/E
—
P/S
—
EPS
0.08
Div yield, %
4.73%
Shrs. gr., 5y
—
Rev. gr., 5y
8.97%
Revenues
8.35b
+1.34%
Net income
929m
-3.71%
CFO
1.65b
-3.43%
Dividend
Aug 27, 20260.02 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chularat Hospital Public Company Limited is a healthcare provider primarily operating clinics and hospitals across Thailand. The company's activities are structured into two main divisions: Hospital Operations and Other Businesses. In addition to its medical facilities, it also engages in the distribution of medical instruments and dietary supplement products. As of December 31, 2021, its network encompassed 14 branches of clinics and hospitals. The company was founded in 1986 and is headquartered in Samut Prakan, Thailand.
Key people
Kriangsak Plussind
Non-Executive Chairman of the Board · since 2004
Jedsada Chokdamrongsuk
Chief Executive Officer, Managing Director, Executive Director · since 2023
Chutima Pincharoen
Deputy Chief Executive Officer, Hospital Director of Chularat 11 International · since 2023
Wandee Pisanuvanavech
Deputy Chief Executive Officer, Company Secretary and Administrative Director · since 2022
Yudthana Sanguansakdikosol
Deputy Chief Executive Officer, Hospital Director of Chularat 9 Airport · since 2023
Suppachoke Rojcheewin
Chief Financial Officer · since 2022
Suchai Laoveerawat
Executive Director, Hospital Director - Chularat 1, 5 · since 2015
Rungarun Santhadkolkarn
Hospital Director · since 2021
Kumpol Plussind
Director · since 2025
Kobkul Panyapol
Non-Executive Director · since 2004
Apirum Panyapol
Non-Executive Director · since 2004
Kannikar Plussind
Non-Executive Director · since 2004
Wichit Siritattamrong
Non-Executive Director · since 2004
Manit Jeeradit
Non-Executive Independent Director · since 2012
Pinit Kullavanijaya
Non-Executive Independent Director · since 2012
Santhat Sanguandikul
Non-Executive Independent Director · since 2022
Somyos Yan-ubol
Non-Executive Independent Director · since 2012
IPO date
May 16, 2013
Employees
Domiciled in
TH
Incorporated in
TH
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |